目的 分析2017-2019年天津醫(yī)科大學(xué)腫瘤醫(yī)院門診藥房麻醉藥品的使用情況和用藥分布，為麻醉藥品在臨床的合理應(yīng)用提供參考。方法 對2017-2019年天津醫(yī)科大學(xué)腫瘤醫(yī)院門診藥房麻醉藥品的銷售金額、用藥頻度（DDDs）、限定日費用（DDC）和排序比（B/A）進行分析。結(jié)果 2017-2019年天津醫(yī)科大學(xué)腫瘤醫(yī)院門診藥房麻醉藥品銷售金額排名基本穩(wěn)定，各藥品的DDDs排名變化不大，硫酸嗎啡緩釋片（30 mg）、芬太尼透皮貼劑（8.4 mg）和芬太尼透皮貼劑（4.2 mg）的DDDs穩(wěn)居前3位。除磷酸可待因外，其他藥品的DDC值穩(wěn)定不變。B/A值最低的為鹽酸羥考酮緩釋片（10 mg），最高的為磷酸可待因片，其他藥品的B/A值均在1左右。結(jié)論 天津醫(yī)科大學(xué)腫瘤醫(yī)院門診藥房麻醉藥品的使用基本合理。

Objective To investigate the usage and drug distribution of narcotic drugs in outpatients of Tianjin Medical University Cancer Institute and Hospital from 2017 to 2019,so as to provide reference for rational clinical application of drugs. Methods The usage of narcotic drugs in outpatients of Tianjin Medical University Cancer Institute and Hospital from 2017 to 2019 were collected, and consumption quantity, consumption sum, defined daily dose system(DDDs), defined daily cost (DDC), and drug sequence ratio (B/A) were calculated and compared. Results From 2017 to 2019, the ranking of sales amount of narcotic drugs in Tianjin Medical University Cancer Institute and Hospital was basically stable, and the ranking of DDDs of narcotic drugs did not changed significantly, and the DDDs of Morphine Sulfate Sustained-release Tablets (30 mg), Fentanyl Transdermal Patches (8.4 mg) and Fentanyl Transdermal Patches (4.2 mg) were in the top three. Except the Codeine Phosphate Tablets, the value of DDC of other drugs was unchanged. The lowest of B/A value was Oxycodone Hydrochloride Prolonged-release Tablets (10 mg), and the highest was Codeine Phosphate Tablets, and the B/A value of other narcotic drugs was close to 1. Conclusion The usage of narcotic drugs of Tianjin Medical University Cancer Institute and Hospital was basically rational.

R971

天津市教委科研計劃項目（2019KJ187）